Medscape

Flawed PSA Data in SEER Make Past Studies Suspect

When the National Cancer Institute (NCI) removed all prostate-specific antigen (PSA) data from the Surveillance, Epidemiology, and End Results (SEER) and SEER-Medicare programs, it rendered many of ...
ascopubs.org

The Surveillance, Epidemiology, and End-Results Program Database as a Resource for Conducting Descriptive Epidemiologic and Clinical Studies

IN THIS issue of the Journal of Clinical Oncology, Anderson et al 1 analyze data from the Surveillance, Epidemiology, and End-Results (SEER) Program to determine whether inflammatory breast cancer ...
The American Journal of Managed Care

Urologist Evaluates Implications of the Removal of Flawed SEER PSA Data

Large data sets like SEER need better quality control checks and researchers and clinicians who use these data sets should also consider using secondary data analyses that answer specific research ...
Medical Xpress

A comprehensive review of early-onset colorectal SEER data is the first to specifically assess adenocarcinomas

In a comprehensive review of SEER (Surveillance, Epidemiology, and End Results) 18 data researchers analyzed histologic colorectal subtypes independently and found that some lesions categorized as ...
The American Journal of Managed Care

More Women Will Be Diagnosed With MCL Through 2032, SEER Data Suggest

SEER-21 (2017-2022) and SEER-Medicare (2012-2021) trends project increasing DLBCL and MCL disease burden through 2032, with expanding treatment-eligible cohorts across lines of therapy. DLBCL ...
Business Wire

Castle Biosciences Collaborates with the National Cancer Institute to Link DecisionDx®-Melanoma Testing Data with SEER Registries’ Cutaneous Melanoma Cases

Analysis of the first subset of linked SEER patient data demonstrates DecisionDx®-Melanoma testing was associated with improved overall survival rates compared to untested patients DecisionDx-Melanoma ...